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Background: Colonization with methicillin-resistant Staphylococcus aureus (MRSA) poses a hygiene risk that does
not spare field hospitals or military medical field camps during military deployments. Diagnostic options for
unambiguously identifying MRSA isolates are usually scarce in military environments. In this study, we assessed the
stepwise application of two different selective agars for the specific identification of MRSA in screening analyses.
Methods: Nasal swabs from 1541 volunteers were subjected to thioglycollate broth enrichment and subsequently
screened on CHROMagar MRSA selective agar for the identification of MRSA. The MRSA identity of suspicious-looking
colonies was confirmed afterwards or excluded by another selective agar, chromID MRSA. All isolates from the selective
agars with MRSA-specific colony morphology were identified by biochemical methods and mass spectrometry.
Results: The initial CHROMagar MRSA screening identified suspicious colonies in 36 out of 1541 samples. A total of 25
of these 36 isolates showed MRSA-like growth on chromID agar. Out of these 25 isolates, 24 were confirmed as MRSA,
while one isolate was identified as Staphylococcus kloosii. From the 11 strains that did not show suspicious growth on
chromID agar, 3 were methicillin-sensitive Staphylococcus aureus (MSSA, with one instance of co-colonization with
Corynebacterium spp.), 2 were confirmed as MRSA (with 1 instance of co-colonization with MSSA), 2 were lost during
passaging and could not be re-cultured, one could not be identified by the applied approaches, and the remaining 3
strains were identified as Staphylococcus saprophyticus, Staphylococcus hominis (co-colonized with Macrococcus
caseolyticus) and Staphylococcus cohnii, respectively.
Conclusions: The application of the selective agar CHROMagar MRSA alone proved to be too non-specific to allow for
a reliable diagnosis of the presence of MRSA. The combined use of two selective agars in a stepwise approach reduced
this non-specificity with an acceptably low loss of sensitivity. Accordingly, such a stepwise screening approach might
be an option for resource-restricted military medical field camps.
Keywords: Methicillin-resistant Staphylococcus aureus, Selective agar, Chromogenic agar, Screening, Hygiene, Stepwise
diagnostics, CHROMagar, ChromID agar* Correspondence: Frickmann@bni-hamburg.de
†Equal contributors
1Department of Tropical Medicine at the Bernhard Nocht Institute, German
Armed Forces Hospital of Hamburg, Hamburg, Germany
3Institute for Microbiology, Virology and Hygiene, University Medicine
Rostock, Rostock, Germany
Full list of author information is available at the end of the article
© 2015 Micheel et al. This is an Open Access
(http://creativecommons.org/licenses/by/4.0),
provided the original work is properly credited
creativecommons.org/publicdomain/zero/1.0/article distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Micheel et al. Military Medical Research  (2015) 2:18 Page 2 of 7Background
Colonization with methicillin-resistant Staphylococcus
aureus (MRSA) poses a relevant public health threat
worldwide. Soldiers are at risk as well, both during exer-
cises and on deployment. MRSA is readily transmissible
and shows high tenacity, potentially leading to outbreak
situations as previously occurred for military trainees in
San Diego, California [1]. The nostrils and mucous mem-
branes of the upper respiratory tract are typical sites of
colonization [2] from which nosocomial spread may
occur. Such colonization with MRSA has been demon-
strated for US soldiers irrespective of their current deploy-
ment situations [3].
The disease spectrum caused by Staphylococcus aureus
ranges from mild to moderate skin and soft tissue infec-
tions to life-threatening systemic infections [4]. Impres-
sively high percentages of MRSA-induced abscesses have
been identified in American soldiers [5].
Increasing numbers of MRSA strains have been iso-
lated in hospitals and community settings since the
introduction of beta-lactam antibiotics [6, 7]. Once
introduced, community-associated MRSA strains can
readily spread within healthcare facilities [8] and pose a
considerable risk for immunologically compromised
trauma patients within military medial field hospitals or
camps on deployment.
Reliable screening procedures are needed for the de-
ployment setting to prevent the spread of MRSA from
colonized patients by the enforcement of adequate hy-
giene precautions. Point-of-care PCR systems such as
GeneXpert (Cepheid, Sunnyvale, California) deliver rapid
results [9]. However, the specificity of the GeneXpert
system has been shown to be reduced in cases of mecA
gene loss [10, 11]; furthermore, such point-of-care de-
vices are not always available.
Chromogenic selective agars are inexpensive and
ready-to-use alternatives or amendments [12] if the basic
laboratory infrastructure needed for the growth of bac-
teria can be provided. Numerous evaluations of MRSA-
selective agars have been introduced [13–56] with
acceptable but still improvable results regarding their
sensitivities and specificities. In this study, we evaluated
a stepwise approach using one selective agar as a screen-
ing method and another agar for confirmation testing.
Methods
A total of 1541 nasal swabs for MRSA screening (agar
gel transport single plastic swabs without charcoal,
Amies w/o Ch, Copan Italia SpA, Brescia, Italy,
108C.USE) were included in the analysis. The nasal ves-
tibulum of healthy adult volunteers was screened using
one swab per study participant. The study population
comprised Madagascan civilians. To ensure the privacy
of the volunteers, no further details regarding thesampling setting are presented for this technical evalu-
ation in accord with our institutes’ ethical standards,
which prohibit the assessment and presentation of pa-
tient data that do not directly impact the scientific ques-
tion being assessed. The descriptive analysis of the
laboratory procedures presented here does not demand
a more detailed presentation of the patient data.
After broth enrichment of the samples in thioglycol-
late broth (BD, Heidelberg, Germany) for 16–24 h at
37 °C, the cultures were grown on the MRSA selective
agar CHROMagar MRSA (MAST Diagnostica, Reinfeld,
Germany) for 40–48 h at 37 °C as an initial screening
step. Suspicious colonies on the CHROMagar MRSA
plates, i.e., mauve-colored colonies, were selected and
stored at -80 °C in Microbank tubes (Pro-Lab Diagnos-
tics, Bromborough, UK) until further assessment.
As a next step, all isolated strains were grown on an-
other MRSA-selective chromogenic agar, chromID MRSA
(bioMérieux, Marcy-l’Étoile, France, reference: Best.-Nr.43
451 (20 units) or Best.-Nr.43 459 (100 units)), for an add-
itional 40–48 h at 37 °C to confirm or contradict the result
of the CHROMagar MRSA-based screening. The isolates
were grown directly from the Microbank tubes.
All suspicious isolates that were confirmed by chro-
mID MRSA testing, i.e., green colonies on the chromID
MRSA agar, were subjected to matrix-assisted laser-
desorption-ionization time-of-flight mass-spectrometry
(MALDI-TOF-MS) by a Shimadzu/Kratos “AXIMA As-
surance” MALDI-TOF mass spectrometer (SHIMADZU
Germany Ltd., Duisburg, Germany) as described [57] for
confirmation on the species level. Spectral fingerprints
were analyzed using Vitek MS IVD V2 database MS-CE
version CLI 2.0.0 (bioMérieux). Commercial BD MAX
MRSA PCR (BD, Heidelberg, Germany) was used to ver-
ify the identity as MRSA.
Isolates from the CHROMagar MRSA that were not
confirmed as MRSA by the growth of suspicious colonies
on chromID MRSA were subjected to the following: re-
peated growth on chromID MRSA agar, penicillin-binding
protein 2a (pbp-2a)-latex agglutination (PBP2a Culture
Colony Test, Alere Scarborough Inc., Scarborough, Maine,
USA), Pastorex Staph-Plus (Bio-Rad, Marnes-la-Coquette,
France) latex agglutination targeting clumping factor, pro-
tein A and capsular polysaccharides, VITEK-II GP-card
(bioMérieux)-based identification and MALDI-TOF-MS
(as described above). Antimicrobial susceptibility testing
of Staphylococcus aureus strains was performed using the
VITEK-II AST-P619-card (bioMérieux) to confirm oxacil-
lin resistance.
For MRSA strains that were incorrectly missed by the
chromID MRSA agar confirmation testing, spa typing
was performed using the Ridom StaphType standard
protocol for PCR and subsequent double-strand sequencing
[58, 59]. Automated sequence allocation was performed
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Ltd., Würzburg, Germany).
This study was approved by the Ethical Committee of
the Ministry of Health of the Republic of Madagascar
prior to being conducted (No. 081 - MSANP/CE, 5th
November 2012).
Results and discussion
From 36 out of the analyzed 1541 nasal swabs from
healthy volunteers, MRSA-suspicious colonies were iso-
lated from the CHROMagar plates after thioglycollate
broth enrichment and freezing at -80 °C in Microbank
tubes. As reported from previous studies, the sensitivity
and specificity of this selective agar for MRSA ranges
from 95.4 % to 100 % and 95 % to 100 %, respectively
[60–62]. From these 36 strains, 2 did not grow after
freezing, so their identity could not be assessed. It is
thus theoretically possible that these strains were indeed
MRSA.
For the remaining 34 strains, 25 grew on the chromID
MRSA agar as MRSA-like green colonies. The previously
described ranges of sensitivity and specificity of chromID
MRSA agar are 64.5 % to 99.4 % and 98.5 % to 99.4 %,
respectively, for the detection of MRSA [63]. From the
25 strains showing green colonies, 24 out of 25 were
confirmed as Staphylococcus aureus by MALDI-TOF-
MS and as MRSA by the commercial BD MAX MRSA
PCR. However, one strain was misidentified by the com-
bined approach based on CHROMagar MRSA and chro-
mID MRSA agar. MALDI-TOF-MS analysis identified
this strain as Staphylococcus kloosii, a coagulase-negative
skin colonizer. For the remaining 9 samples, no growth
of the culture or growth of non-suspicious white col-
onies were observed on chromID MRSA agar. Photo-
graphs showing the typical examples of the colony
morphology on CHROMagar MRSA for 4 out of these 9
samples are depicted in Fig. 1.
These 9 samples were further investigated by mass
spectrometry and biochemical approaches. As described
in previous reports [61], small purple colonies of skin-
colonizing Corynebacterium spp. on CHROMagar MRSA
medium might be misidentified as potential MRSA strains
by non-experienced investigators.
For one sample, the identification of tiny colonies
failed. For three samples, the colonies were identified as
coagulase-negative staphylococci, while the VITEK-II
GP-cards and MALDI-TOF-MS unanimously identified
Staphylococcus saprophyticus, Staphylococcus hominis
and Staphylococcus cohnii in these cases. From the sam-
ple containing the Staphylococcus hominis strain, the
skin-colonizer Macrococcus caseolyticus was also isolated
and identified by mass spectrometry. In another three sam-
ples, methicillin-sensitive Staphylococcus aureus (MSSA)
was confirmed; methicillin-susceptibility was monitored bypbp-2a-agglutination and VITEK-II AST-619 antimicrobial
susceptibility testing. Corynebacterium spp. was observed
to be co-colonized with MSSA in one instance.
MRSA was confirmed in two of nine samples, in spite
of an initial non-suspicious growth on chromID MRSA
agar. However, after repeated growth on chromID
MRSA agar, typical green colonies were identified. One
of these two MRSA strains did not show characteristic-
ally green colonies earlier than 48 h of growth; an add-
itional MSSA strain was isolated from this same sample.
The reasons remain unclear why those two additional
MRSA strains did not show typical colony color and
morphology during the first assessment on chromID
MRSA agar. A possible reason might be the fact that the
first growth on chromID MRSA agar was performed
directly from the Microbank tubes, as strains can tend
to grow atypically immediately after thawing after pro-
longed storage at -80 °C.
To further characterize the two MRSA strains that
were missed by initial chromID MRSA agar confirm-
ation testing, spa typing [58, 59] was performed. This
rapid and easy-to-use sequence-based molecular tool al-
lows for international phylogenetic comparisons and has
widely replaced pulsed field gel electrophoresis as the
new gold standard of Staphylococcus aureus typing in
Germany [64]. The identified spa types were t314 for the
strain that grew after 48 h of incubation on chromID
MRSA agar only and t186 for the other strain. The t314
clone is known to be prevalent in Western Africa [65]
and the t186 clone in Eastern Africa [66].
In summary, MRSA strains were identified by the ap-
plied procedures in 26 of 1541 samples. A combined ap-
proach of CHROMagar MRSA selective agar as a
screening tool and chromID MRSA agar as a confirm-
ation tool after thioglycollate broth enrichment identi-
fied 24 out of 26 MRSA strains but initially missed two
strains. In contrast, a Staphylococcus kloosii strain, which
is rarely isolated from human samples, was erroneously
considered to be MRSA.
However, one incorrectly attributed strain out of a
total of 1541 samples represents an acceptable specificity
of the approach. The total sensitivity cannot be esti-
mated, as there was no comparative gold standard for
the CHROMagar MRSA screening. Accordingly, one
cannot say how many MRSA strains were missed by the
initial screening.
The significant advantage of CHROMagar MRSA is
the fact that the manufacturer sells the agar not only as
ready-to-use agar plates but also as a powder, allowing
for easy shipment without proper cooling and produc-
tion of the plates at the site of deployment. However, if
the storage of the powder for up to 2 years is intended,
the manufacturer recommends storage at 2 °C to 8 °C.
The high number of false positive results due to
Fig. 1 Difficult to discriminate: colony morphology as observed during the CHROMagar MRSA screening. a) Staphylococcus hominis. b) Confirmed as
MRSA. c) Methicillin-sensitive Staphylococcus aureus. d) Staphylococcus cohnii
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cern, resulting in an insufficient specificity. The design
of the study does not allow for statements on the specifi-
city of a screening based on the solitary use of chromID
MRSA agar, as this selective agar was used for confirm-
ation testing only.
However, this was not the only limitation of this study.
The fact that the initial inoculation was confined to just
one MRSA screening agar was admittedly a major draw-
back. Accordingly, no proper comparison was possible.
The stepwise approach described in this study was a de-
scription of field experience and not a comparative study.
The consequences of incorrect suspicions of colonization
with MRSA are considerable. This is particularly true if iso-
lation of MRSA-positive patients is enforced as a strategy
to prevent nosocomial spread in the field hospital. As
shown in several studies [67, 68], the isolation of colonized
patients leads to reduced nursing quality with poorer out-
comes as a result. Accordingly, the usefulness of screeningprocedures has been discussed with much controversy [69].
The repeated disinfecting washing of all patients without
regard to colonization status would be an alternative re-
garding infection control [70–72] but has not yet been im-
plemented widely.
Conclusions
If MRSA screening is needed in a resource-restricted
medical field camp environment where no alternative
approaches for reliable confirmation testing are available,
screening with two different MRSA selective agars is an
option with an acceptable specificity. CHROMagar
MRSA powder can be easily shipped to sites of tropical
deployment but bears the risk of misidentifying coagulase-
negative staphylococci and MSSA as MRSA if it is used
without confirmation testing. Due to the harmful conse-
quences of isolation of MRSA-colonized patients, incor-
rect identification of colonization with MRSA should be
avoided.
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